EagleClaw Capital Managment LLC Has $8.24 Million Holdings in CME Group Inc. (NASDAQ:CME)

EagleClaw Capital Managment LLC lessened its stake in CME Group Inc. (NASDAQ:CME) by 0.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 37,330 shares of the financial services provider’s stock after selling 110 shares during the quarter. CME Group comprises 1.4% of EagleClaw Capital Managment LLC’s investment portfolio, making the stock its 24th biggest position. EagleClaw Capital Managment LLC’s holdings in CME Group were worth $8,237,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bessemer Group Inc. raised its stake in CME Group by 416.7% during the first quarter. Bessemer Group Inc. now owns 21,365 shares of the financial services provider’s stock worth $4,599,000 after acquiring an additional 17,230 shares in the last quarter. Pitcairn Co. increased its stake in shares of CME Group by 11.7% in the first quarter. Pitcairn Co. now owns 2,684 shares of the financial services provider’s stock valued at $578,000 after buying an additional 282 shares during the period. Crewe Advisors LLC acquired a new position in shares of CME Group in the first quarter valued at approximately $120,000. CreativeOne Wealth LLC acquired a new position in shares of CME Group in the first quarter valued at approximately $315,000. Finally, Sheaff Brock Investment Advisors LLC increased its stake in shares of CME Group by 1.1% in the first quarter. Sheaff Brock Investment Advisors LLC now owns 61,467 shares of the financial services provider’s stock valued at $13,233,000 after buying an additional 648 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on CME shares. Bank of America upped their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research note on Tuesday, October 8th. JPMorgan Chase & Co. upped their target price on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $224.47.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the sale, the director now directly owns 10,589 shares of the company’s stock, valued at $2,403,279.44. The trade was a 8.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock worth $3,441,063 in the last ninety days. Corporate insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.1 %

Shares of CME Group stock traded up $0.21 on Wednesday, reaching $229.87. 66,229 shares of the company’s stock were exchanged, compared to its average volume of 1,903,918. The company has a market capitalization of $82.84 billion, a P/E ratio of 24.15, a price-to-earnings-growth ratio of 5.20 and a beta of 0.55. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.74. The firm’s 50-day moving average is $223.02 and its two-hundred day moving average is $210.69. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the prior year, the business earned $2.25 EPS. Sell-side analysts predict that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.